newsfilter
← Latest News
GlobeNewswire·

Impel NeuroPharma to Report Second Quarter 2021 Financial Results on Monday, August 16, 2021

SEATTLE, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Impel NeuroPharma, Inc. (NASDAQ:IMPL), a late-stage biopharmaceutical company focused on the development and commercialization of transformative therapies for patients living with central nervous system (CNS)